News and Breakthroughs
Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the Lurie Cancer Center news archive.
Visit our gallery to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.
Northwestern Medicine scientists have discovered the Achilles heel of chemotherapy-resistant ovarian cancer — its hunger for cholesterol — and how to sneakily use that to destroy it.
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis recently published in the Journal of Clinical Oncology.
Increased expression of specific genes in prostate cancer patients may predict whether or not the cancer will respond well to hormone therapy, according to a new study published in Nature Communications.
Thanks to advancements in synthetic biology, scientists are now engineering bacterial communities with the goal of using these cells to monitor and treat diseases. In this episode, Arthur Prindle, PhD, explains how his lab is reprogramming bacteria that may be used in the future to detect disease and deliver therapeutics for many different conditions, including cancer, diabetes and inflammatory bowel disease.
In findings published in Nature, scientists may have found a way around the limitations of engineered T-cells by borrowing a few tricks from cancer itself.
On Friday, March 8, Christopher George, MD, will hit the dance floor to raise funds for transformational breast cancer research and care at Northwestern Medicine and Lurie Cancer Center. Read how he’s preparing for “Dancing with Chicago Celebrities” and support his efforts as a “Corporate Superstar”
A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology.
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
A multidisciplinary team of investigators has developed a first-of-its-kind interactive 3D spatial approach that reveals new therapeutic targets and provides a comprehensive three-dimensional view of glioblastoma tumors, detailed in a recent study published in Cell.
Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies, according to recent findings published in the Journal of Clinical Investigation.
On Monday, January 15, we honor the life and legacy of Dr. Martin Luther King Jr. The Northwestern community will celebrate Dr. King with an expanded special commemoration including events and projects throughout the month.
Some strains of an antibiotic-resistant bacteria may not turn out to be as aggressive as previously thought, according to a Northwestern Medicine study recently published in Nature Communications.
Northwestern Medicine investigators have discovered that specialized immune cells within the glioblastoma tumor microenvironment use a unique “feeding” mechanism that promotes tumor growth and treatment resistance, according to findings published in the journal Cell Metabolism.
Northwestern Medicine investigators have successfully localized novel molecular mechanisms behind a genetic mutation found in a wide range of cancers, which could serve as a biomarker for improving patient stratification and treatment, according to findings published in Proceedings of the National Academy of Sciences.
Decreased activity of a specific signaling pathway in the brain vessels of aging mice and humans was linked to a decline in vascular function and subsequent neurodegeneration, according to a recent Northwestern Medicine study published in the Journal of Clinical Investigation.
Nine Lurie Cancer Center members were named to the 2023 list of Highly Cited Researchers, published by Clarivate Analytics. The annual list identifies investigators who have demonstrated significant and broad influence in their chosen fields through the publication of multiple highly cited papers during the past decade.
A new AI tool may make it possible to spare breast cancer patients unnecessary chemotherapy treatments by using a more precise method of predicting their outcomes, reports a new Northwestern Medicine study published in Nature Medicine.
Men with hormone-resistant prostate cancer and specific genetic mutations who were treated with the drug olaparib survived longer than men treated with traditional hormone therapy, according to a post hoc analysis published in the Journal of Clinical Oncology.
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss exciting new research and important clinical findings at the American Society of Hematology (ASH) Annual Meeting, December 9-12 in San Diego, California. With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
Feeling on cloud nine, I could see my future blooming into everything I wanted and more, until one day, I felt a lump in my breast. I had just turned 26 and although I didn't have family history, I decided to get it checked out. After a mammogram, ultrasound and biopsy, I received a call from a nurse telling me I tested positive for invasive ductal carcinoma breast cancer.
Scientists have found a highly accurate way to predict the best cancer treatment for patients based on patterns of gene expression in their tumors.
Research potentially removes barriers for promising cell and gene therapies
- Hippocratic Cancer Research Foundation Gala Raises More Than $1.1 Million to Benefit Lurie Cancer Center11.22.2023
On Saturday, November 11, the Hippocratic Cancer Research Foundation’s Wings to Cure eighth annual gala raised more than $1.1 million to advance innovative cancer research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
The Robert H. Lurie Comprehensive Cancer Center’s SPORE in Prostate Cancer and Polsky Urologic Cancer Institute announce the following awards in support of innovative prostate cancer research.
Investigators led by Neil Kelleher, PhD, have developed an automated technique for imaging proteoforms in ovarian cancer, according to results published in Nature Communications.
Saving more lives through groundbreaking research – and improving the lives of all people facing cancer – is the mission of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
In a recent article published in Molecular Cell, the laboratory of Ali Shilatifard, PhD, provided a comprehensive overview of the current understanding of the elongation stage of DNA transcription and how its dysregulation is associated with developmental defects, disease and aging.
Northwestern Medicine investigators have identified a novel therapeutic agent that is effective in treating metastatic cancer and brain metastases, according to a recent study published in the Journal of Clinical Investigation.
Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a study published in ACS Nano.
See more news in the article archive.